In search of viable SARS-CoV-2 in the tear film: a prospective clinical study in hospitalized symptomatic patients

por Leysen, Laura, Delbeke, Heleen, Desmet, Stefanie, Schauwvlieghe, Pieter-Paul, Maes, Piet, Blanckaert, Gauthier, Matthys, Emiel, Joossens, Marie, Casteels, Ingele
Publicado 2022

COVID-19 vaccine: missed opportunities and hospital vaccine implementation

por Martinot, Martin, Mohseni-Zadeh, Mahsa, Marion, Laurent, Roncalez, Daniel
Publicado 2022

Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response

por Ranzani, Otavio T., Bozza, Fernando A.
Publicado 2022

Learning from and optimising divergent pandemic responses

por Tang, Julian W., Kwok, Kin On
Publicado 2022

Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2: a prospective multicenter cohort study

por Massalha, Manal, Yefet, Enav, Rozenberg, Orit, Soltsman, Sofia, Hasanein, Jamal, Smolkin, Tatiana, Alter, Adi, Perlitz, Yuri, Nachum, Zohar
Publicado 2022

Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seroneg...

por Tabarsi, Payam, Anjidani, Nassim, Shahpari, Ramin, Mardani, Masoud, Sabzvari, Araz, Yazdani, Babak, Roshanzamir, Khashayar, Bayatani, Behnam, Taheri, Ali, Petrovsky, Nikolai, Li, Lei, Barati, Saghar
Publicado 2022

The COVID-19 vaccine health pass fraud in France

por Zucman, David, Fourn, Erwan, Vallée, Alexandre
Publicado 2022

Re: Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients by Peghin et al.

por Sookaromdee, Pathum, Wiwanitkit, Viroj
Publicado 2022

SARS-CoV-2 vaccine humoral response in adults with Down syndrome

por Sali, Michela, Carfì, Angelo, Di Paola, Antonella, Pereyra Boza, Maria, Zampino, Giuseppe, Sanguinetti, Maurizio, Landi, Francesco, Onder, Graziano
Publicado 2022

Analyzing COVID-19 vaccine efficacy in vulnerable communities: efforts beyond addressing vaccine inequity

por Sendi, Parham, Tande, Aaron J.
Publicado 2022

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients w...

por Ader, Florence
Publicado 2022

First-generation oral antivirals against SARS-CoV-2

por Sendi, Parham, Razonable, Raymund R., Nelson, Sandra B., Soriano, Alex, Gandhi, Rajesh Tim
Publicado 2022

Re: Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2 by Massalha et al.

por Zeng, Guangting
Publicado 2022

Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.

por Mori, Nobuaki
Publicado 2022

Omicron (B.1.1.529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other variants of concern and impact on diagnostic testing strategy

por Matic, Nancy, Lowe, Christopher F., Ritchie, Gordon, Young, Matthew, Lawson, Tanya, Romney, Marc G.
Publicado 2022

Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis

por Pereson, Matías J., Amaya, Lucas, Neukam, Karin, Baré, Patricia, Echegoyen, Natalia, Badano, María Noel, Lucero, Alicia, Martelli, Antonella, Garcia, Gabriel H., Videla, Cristina, Martínez, Alfredo P., Di Lello, Federico A.
Publicado 2022

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab

por Vellas, Camille, Trémeaux, Pauline, Del Bello, Arnaud, Latour, Justine, Jeanne, Nicolas, Ranger, Noémie, Danet, Chloé, Martin-Blondel, Guillaume, Delobel, Pierre, Kamar, Nassim, Izopet, Jacques
Publicado 2022

Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis

por Lee, Todd C., Murthy, Srinivas, Del Corpo, Olivier, Senécal, Julien, Butler-Laporte, Guillaume, Sohani, Zahra N., Brophy, James M., McDonald, Emily G.
Publicado 2022

Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity

por Bae, Seongman, Ko, Jae-Hoon, Choi, Ju-Yeon, Park, Woo-Jung, Lim, So Yun, Ahn, Jin Young, Song, Kyoung-Ho, Lee, Kyoung Hwa, Song, Young Goo, Chan Kim, Yong, Park, Yoon Soo, Choi, Won Suk, Jeong, Hye Won, Kim, Shin-Woo, Kwon, Ki Tae, Kang, Eun-Suk, Kim, Ah-Ra, Jang, Sundong, Kim, Byoungguk, Kim, Sung Soon, Jang, Hee-Chang, Choi, Jun Yong, Kim, Sung-Han, Peck, Kyong Ran
Publicado 2022

Safe university: a guide for open academic institutions through the pandemic

por Wallace, Manolis, Pappas, Georgios
Publicado 2022